MedTrace Logo

Preventability of Infections in Residents of French Nursing Homes

NCT01069497 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3500

Last updated 2010-02-17

No results posted yet for this study

Summary

STUDY HYPOTHESIS : An infection prevention program adapted for the nursing home context can reduce by 5% the number of infections (urinary, upper and lower respiratory and gastrointestinal) in elderly residents in nursing homes.

STUDY DESIGN : The proposal is for an interventional cluster (nursing home) study comprising 2 randomized groups: group 1 (interventional), comprising 25 nursing homes implementing a specific infection prevention program; and group 2 (control), 25 nursing homes continuing to implement their routine prevention measures.

Conditions

  • Infection Control

Interventions

OTHER

Prevention of infections program

The intervention mainly involves implementing urinary, respiratory and gastrointestinal infection prevention measures. Study nursing home medical coordinators will be in charge of training their own teams. For this, they will be provided with: * a slide-show of recommendations (commented by an expert), * recommendations guides (on paper and on computer) to be shown to their teams. Means will be provided to the intervention nursing homes : Hydro-alcoholic solutions, disinfectant detergent-impregnated tissues, mouth care kits, tec.

Sponsors & Collaborators

  • Ministry of Health, France

    collaborator OTHER_GOV

  • Pierre Fabre Laboratories

    collaborator INDUSTRY

  • Gaba Laboratories

    collaborator OTHER

  • Observatoire du Risque Infectieux en Gériatrie

    lead OTHER

Principal Investigators

  • Monique Rothan Tondeur, PhD · ORIG, EHESP

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-04-30
Completion
2010-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01069497 on ClinicalTrials.gov